OVESTIN ovule 0.5 mg 15 pce
7680471830141
CH-47183
G03CA04
07.08.2.
1 / 3
google
Details
- Product number
- 4718301
- CPT
- -
- Packaging group
- 15
- Unit
- Suppositorien
- Composition
- estriolum 0.5 mg, adeps solidus, glyceroli monoricinoleas, macrogoli aether cetostearylicus, E 321 0.03 mg, E 304, acidum citricum, propylenglycolum, pro ovulo.
Articles (1)
Ovestin Ovula, Vaginalovula
Vaginalovula
15
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.03 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | ANTON |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 14.45
Specialties list
Yes
Generic
No
SL addition date:
15/03/1988
Authorization holder
Aspen Pharma Schweiz GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 47183
- Drug name
- Ovestin Ovula, Vaginalovula
- Galenic form
- VAGZ
- ATC Code
- G03CA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 31/08/1987
- Authorization expiration date
- 31/12/9999
- IT number
- 07.08.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OVESTIN ovule 0.5 mg 15 pce
- Description (DE)
- OVESTIN Ovula 0.5 mg 15 Stk
- Market launch
- 31/08/1987
- Narcotic (BTM)
- No